Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 456 participants.

Also called NCT02484027

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 456 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02484027
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02484027. Randomized; no masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2017-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS)
Acronym
REPAIRS
Condition
Infarction, Anterior Cerebral Artery
Intervention (Drug)
Rosuvastatin
Lead sponsor
Second Affiliated Hospital of Soochow University (class: other)
Collaborator
Taicang No.1 People's hospital (class: not stated)
Collaborator
AstraZeneca (class: industry)
Collaborator
National Natural Science Foundation of China (class: other government)

Record details

Record id
cardio:ct-nct02484027
Content hash
7ba7b5cde9f8944a2090e4febc38c2af26af69e71f75e8f30f3861cfbd350b0f